Several studies have confirmed that JQ1 attenuated fibrosis and inflammation resulting from radiation used in radiotherapy in thoracic cancer by suppressing BRD4, c-MYC, p65 NF-κB, and the COLII/TGF-β/SMAD pathway [29]. Here, MYC is linked to thoracic cancer.